Characteristic | Number of patients | |||||
---|---|---|---|---|---|---|
Four consecutive weeks | 2-week on/1-week off | |||||
5 mg/person | 10 mg/person | 10 mg/person | 12 mg/person | 16 mg/person | ||
Total | 4 | 4 | 3 | 21 | 3 | |
Sex | Male | 2 | 2 | 2 | 15 | 1 |
Female | 2 | 2 | 1 | 6 | 2 | |
Age, year | Median | 39 | 50 | 60 | 47 | 45 |
Range | 21–49 | 39–60 | 53–65 | 32–60 | 48–55 | |
ECOG score | 0 | 0 | 1 | 0 | 9 | 0 |
1 | 4 | 3 | 3 | 12 | 3 | |
Pretreatment | Surgery | 3 | 4 | 2 | 18 | 2 |
Radiotherapy | 2 | 1 | 3 | 6 | 1 | |
Chemotherapy | 4 | 4 | 3 | 15 | 3 | |
Tumor site | Sarcoma | 2 | 1 | 1 | 4 | 1 |
MTC | 0 | 0 | 0 | 6 | 0 | |
CC | 1 | 2 | 0 | 0 | 1 | |
NSCLC | 0 | 0 | 1 | 3 | 0 | |
RC | 0 | 0 | 0 | 4 | 0 | |
Other | 1 | 1 | 1 | 4 | 1 |